Interim Results

McBride PLC 30 March 2001 30 March 2001 McBride plc Interim results for the six months ended 31 December 2000 McBride is Europe's leading supplier of household and personal care retailer brand products and Europe's leading independent retailer brand and contract supplier of OTC pharmaceuticals. Highlights * Sales grew by 4.2% in local currency terms * Sterling reported sales of £247.8 million up 1.9% * Progress in core household and personal care sectors assisted by recovery in private label demand * Margins reduced by raw material, packaging and fuel price inflation exacerbated by the Euro's weakness against the US Dollar * Operating profit £11.5 million before goodwill amortisation and share of joint venture * Profit before taxation, goodwill amortisation and share of the joint venture £7.0 million * Basic earnings per share 2.8p before share of joint venture and goodwill amortisation * Given reduced profitability for the year to date the Board has decided to wait until the year end before recommending the level of dividend * Discussions continue regarding options to enhance shareholder value and an announcement will be made when appropriate Commenting on the results, Mike Handley, Chief Executive said: 'Although market conditions in both the UK and Continental Europe continue to be challenging, a number of measures have been implemented to improve sales volumes, increase sales revenues and ensure all costs remain tightly controlled. Despite these actions the Board believes that the results for the year ending 30 June 2001 are likely to fall short of current market expectations. We believe that the cycle of oil-related chemical input cost increases has already peaked and this should be reflected in future results. The last peak in 1995/96 had a similar impact. On 26 September 2000 McBride announced that it had received a number of preliminary enquiries from interested parties concerning a possible offer for the company. Discussions are continuing and whilst there can be no certainty at this stage that any transaction will result, an announcement will be made as further developments occur.' For further information please contact: Financial Dynamics 020 7831 3113 Fiona Meiklejohn BSMG Worldwide direct 020 7841 5542 David Walker switchboard 020 7841 5555 INTERIM REVIEW In the first six months of the financial year McBride's sales were £247.8 million, an increase of 1.9% compared with the first half of the previous year. Allowing for the effect of currency movements, underlying sales growth was 4.2%. In its core private label product sectors, McBride's underlying growth was 6.5%, the difference reflecting the continuing reduction in contract manufacturing activities. Volume trends were generally healthy in all markets, but especially in Continental Europe and internationally where several important new contracts were won. Private label experienced a renewed upturn in demand among all leading retailers after a static period between 1999 and 2000 when heavy promotion of manufacturer brands temporarily halted the long term growth pattern of private label. There were also important new product developments in which McBride played a leading role. The new tablet format for laundry detergents, which has been a key area of investment for McBride, came close to taking a 30% share of the UK laundry detergent market, displacing traditional standard powders. Concentrated liquids and powders, again a key feature of recent McBride investment, also saw improved levels of demand. Despite an improved level of sales, increases in the prices of raw materials, packaging and fuel, coming at the same time as competitive pressure in the main markets, eroded margins and profitability. This was exacerbated by adverse currency movements particularly affecting raw materials priced in US Dollars. Group operating profit before goodwill amortisation and the contribution from the Aerosol Products Limited joint venture was £11.5 million compared with £ 17.2 million in the previous half year. The major part of this profit shortfall was caused by input cost inflation. Given the reduced profitability for the year to date, the Board has decided to wait until the full results for the year ending 30 June 2001 before recommending the level of dividend for the year. Discussions continue regarding options to enhance shareholder value and an announcement will be made when appropriate. United Kingdom Sales were £136.7 million compared with £135.7 million in the first half of last year, including a performance above expectations from Wrafton Laboratories which was acquired in September 1999. Wrafton's sales were £15.4 million compared with £6.8 million for the three month period from October to December 1999. In the household products sector core sales rose 2.5%, while in personal care core sales rose 4.5%. Private label resumed its long-term growth pattern and achieved new records in market share during the second half of calendar year 2000. In household products, private label's share rose from 23.0% to 23.8%. Within the household market sector tablets, concentrated liquids and powders all increased, playing to McBride's strengths following recent investment. Machine dishwash also increased share. Fabric conditioners, washing up liquid, household cleaners and toilet care were broadly stable. These gains in the household sector were partly offset by a 1% decline in private label's share of the personal care market but McBride's 4.5% increase in core personal care sales reflected a credible increase in share of the available market. Total operating profit in the UK, before goodwill amortisation and share of the Aerosol Products Limited joint venture, was £8.2 million compared with £ 9.2 million in the first half of the previous year, including £2.3 million from Wrafton Laboratories compared with £0.8 million for the period October to December 1999. Margins in household and personal care were affected by higher raw material, packaging, warehousing and transport costs. Expansion and reorganisation at Wrafton's OTC pharmaceuticals business, which included the application of the private label skills of the Group, delivered a very satisfactory increase in operating profits. During the first half of the year McBride bought the shares of two retiring directors to bring the total holding in Wrafton to 92.5% by 31 December 2000. Continental Europe Sales in Continental Europe were £111.1 million compared with £115.2 million in the first half of the previous year. In local currency terms core sales grew by 1.1%. In the household sector sales grew 0.8%, underpinned by good sales growth in France and Belgium where the private label market was much improved, but offset by declines in Holland and Italy where heavy brand promotions continued to restrict private label growth. Personal care sales grew 3.5%, again with encouraging performances in France, Belgium and Poland but broadly static in Holland and Italy. As in the UK, private label and minor brand market growth resumed after a static period. Tablets and concentrates stood out in all countries as the main growth feature. In Poland and other Central and Eastern Europe (CEE) countries the market is still at an early stage of development. However, relationships continued to strengthen with many of the Western European retailers who are investing heavily in these countries and encouraging their established private label suppliers to partner with them. Operating profit before goodwill amortisation was £3.3 million compared with £ 8.0 million in the first half last year. Continental Europe experienced greater margin pressure than that affecting the UK, resulting from higher raw material, fuel and transport costs. However, the principal contributory factor was the continuing adverse effect of the weak Euro on petro-chemical and pulp prices, which added significantly to the input costs. While many steps have been taken within the business to recover the operating margin, it has been necessary to raise selling prices on many products. These price increases are being progressively implemented during the second half of the financial year. Joint Venture The Aerosol Products Limited joint venture with Nichol Beauty Products saw a significant improvement in the level of customer service during the first half of the financial year. However, there were availability problems together with price increases on certain key packaging and raw material items in the October to December period. The combination of these costs, and those incurred to rebuild satisfactory customer service levels, resulted in the need to increase selling prices during early 2001. Lower than expected sales volumes combined with cost pressures resulted in the company incurring a loss in the period. McBride's share of this loss was £1.3 million before goodwill amortisation and interest. The Company will benefit from more stable customer service and the expectation of improved sales volumes with many customers. Financial Summary In the first six months of the financial year net interest costs were £4.5 million compared with £2.5 million for the comparative period of last year. The rise of £2.0 million was due to increased borrowings required to fund recent acquisitions together with the effect of reduced cash generation and higher interest rates for both Sterling and the Euro. The charge for taxation, which amounts to £1.7 million, has been calculated at 25% which is the same percentage rate as last year and represents the estimated effective rate for the current financial year. Capital expenditure in the first half of the year was £8.7 million compared with £9.5 million for the comparative period last year. The main items of capital expenditure were additional manufacturing equipment to support the growth in demand for automatic dishwash and textile tablets together with a new mixing installation for the Polish factory to meet the continuing growth in demand for their range of liquid products. Cash flow from operating activities was £16.0 million compared with £24.5 million in the first half of last year, which reflected lower operating profits and an increase in working capital. Net debt of £123.6 million at the end of December 2000 compared with £115.0 million at June 2000 and £105.0 million at December 1999. Equity shareholders funds at 31 December 2000 increased to £71.0 million compared with £68.3 million at June 2000 and £63.3 million at December 1999. Outlook Although market conditions in both the UK and Continental Europe continue to be challenging, a number of measures have been implemented to improve sales volumes, increase sales revenues and ensure all costs remain tightly controlled. Customer service levels are being sustained at significantly improved levels throughout the business. In the UK, increased customer promotions are expected in the second half of the year while in Continental Europe price increases are being implemented across a wide range of products. All these actions are expected to deliver an improvement in financial performance in the second versus the first half of the financial year. The Board believes that the cycle of oil-related chemical input cost increases has already peaked, and this should be reflected in future results, although the results for the year ending 30 June 2001 are likely to fall short of current market expectations. On 26 September 2000 McBride announced that it had received a number of preliminary enquiries from interested parties concerning a possible offer for the company. Discussions are continuing and whilst there can be no certainty at this stage that any transaction will result, an announcement will be made as further developments occur. In addition the Board continues to examine all possible options to enhance shareholder value. Consolidated profit and loss account Unaudited Unaudited Audited 6 months 6 months Year ended to to 31 Dec 31 Dec 30 June 2000 1999 2000 Note £m £m £m Turnover:Group and share of joint 257.6 255.2 511.1 venture Less: share of joint venture's turnover (9.8) (4.3) (14.3) 247.8 250.9 496.8 Group turnover excluding business transferred to J.V. 247.8 243.1 489.0 UK Aerosol activities transferred to J.V. - 7.8 7.8 Group turnover 1 247.8 250.9 496.8 Cost of sales (158.6) (156.9) (311.5) Gross profit 89.2 94.0 185.3 Distribution costs (12.7) (11.7) (23.3) Administrative costs (65.0) (65.1) (129.5) Group operating profit before goodwill amortisation 1 11.5 17.2 32.5 Goodwill amortisation (1.0) (0.5) (1.5) Group operating profit 10.5 16.7 31.0 Share of joint venture's operating loss before goodwill amortisation (1.3) (0.1) (2.2) Goodwill amortisation on joint venture (0.2) (0.1) (0.2) Share of joint venture's operating loss (1.5) (0.2) (2.4) Profit on disposal of fixed assets - - 3.4 Loss on transfer of business to joint - (2.8) (2.9) venture Group interest receivable and similar 0.1 - 0.2 charges Group interest payable and similar (4.6) (2.5) (6.6) charges Share of joint venture's net interest payable and similar charges (0.4) - (0.4) Profit on ordinary activities before 4.1 11.2 22.3 taxation Tax on profit on ordinary activities 2 (1.7) (3.7) (6.5) Profit on ordinary activities after 2.4 7.5 15.8 taxation Equity minority interest (0.3) (0.2) (0.4) Profit for the period 2.1 7.3 15.4 Dividends 0.0 (4.6) (8.2) Retained profit for the period 2.1 2.7 7.2 Earnings per ordinary share (pence) * Basic and diluted 1.2 4.1 8.7 * Basic before operating exceptional items, share of joint venture and goodwill 2.8 6.1 10.8 amortisation Consolidated balance sheet Unaudited Unaudited Audited 31 Dec 2000 31 Dec 1999 30 June 2000 Note £m £m £m Fixed assets Intangible assets 29.7 27.2 26.5 Tangible assets 153.4 146.7 153.8 Investment in joint venture 7.3 7.6 7.5 Total fixed assets 190.4 181.5 187.8 Current assets Stocks 58.6 58.6 59.0 Debtors 95.9 93.3 104.8 Cash at bank in hand 4.1 1.0 8.2 158.6 152.9 172.0 Creditors: amounts falling due within one year (145.4) (160.3) (167.4) Net current assets 13.2 (7.4) 4.6 Total assets less current 203.6 174.1 192.4 liabilities Creditors: amount falling due after more than one year (124.2) (104.4) (116.8) Provisions for liabilities and (0.9) (2.9) (0.9) charges Investment in joint venture Share of gross assets 7.5 13.1 10.5 Share of gross liabilities (14.3) (15.5) (15.7) Net investment in joint venture (6.8) (2.4) (5.2) Net assets 71.7 64.4 69.5 Capital and reserves Called up share capital 17.8 17.8 17.8 Share premium account 139.3 139.3 139.3 Profit and loss account 5 (86.1) (93.8) (88.8) Equity shareholders' funds 71.0 63.3 68.3 Equity minority interest 0.7 1.1 1.2 Net assets 71.7 64.4 69.5 Consolidated cash flow statement Unaudited Unaudited Audited 6 months to 6 months to Year ended 31 Dec 2000 31 Dec 1999 30 June 2000 Note £m £m £m Cash flow from operating activities 6 16.0 24.5 43.0 Returns on investments and servicing of Finance (4.8) (2.3) (6.2) Taxation (1.9) (0.5) (5.3) Operating cash flow after taxation and finance costs 9.3 21.7 31.5 Capital expenditure (8.7) (9.5) (21.9) Acquisitions (6.6) (22.7) (24.5) Equity dividends paid (3.6) (8.9) (13.5) Financing 7.3 15.7 28.8 Increase/(decrease) in cash in the (2.3) (3.7) 0.4 period Reconciliation of net cash flow to movement in net debt Unaudited Unaudited Audited 6 months 6 months Year ended to to 31 Dec 31 Dec 30 June 2000 1999 2000 £m £m £m Increase/(decrease) in cash in the period (2.3) (3.7) 0.4 Cash outflow from movement in debt and lease financing (7.3) (15.7) (28.8) Change in net debt resulting from cash flows (9.6) (19.4) (28.4) Loans and finance leases acquired with - (2.6) (2.6) subsidiary Translation differences 1.0 3.3 2.3 Movement in net debt in the period (8.6) (18.7) (28.7) Net debt at the beginning of the period (115.0) (86.3) (86.3) Net debt at the end of the period (123.6) (105.0) (115.0) Consolidated statement of total recognised gains and losses Unaudited Unaudited Audited 6 months to 6 months to Year ended 31 Dec 2000 31 Dec 1999 30 June 2000 £m £m £m Profit after tax 2.1 7.3 15.4 Unrealised foreign currency differences 0.6 (0.7) (0.2) Total recognised gains and losses 2.7 6.6 15.2 Reconcilation of movements in shareholders' funds Unaudited Unaudited Audited 6 months to 6 months to Year ended 31 Dec 2000 31 Dec 1999 30 June 2000 £m £m £m Profit for the financial year 2.1 7.3 15.4 Equity dividends 0.0 (4.6) (8.2) Retained profit 2.1 2.7 7.2 Unrealised foreign currency differences 0.6 (0.7) (0.2) Goodwill written back to profit and loss - 10.4 10.4 account Opening equity shareholders' funds 68.3 50.9 50.9 Closing shareholders' funds 71.0 63.3 68.3 Notes to the interim financial statements 1) Segmental information Unaudited Unaudited Audited 6 months 6 months Year ended to to 31 Dec 31 Dec 30 June 2000 1999 2000 £m £m £m Turnover by destination is analysed by geographical area as follows: UK 135.0 131.9 269.5 Continental Europe 110.4 116.6 223.0 Rest of world 2.4 2.4 4.3 247.8 250.9 496.8 Share of joint venture's turnover 9.8 4.3 14.3 257.6 255.2 511.1 Turnover by geographical origin is analysed as follows: UK 136.7 135.7 274.4 Continental Europe 111.1 115.2 222.4 247.8 250.9 496.8 Share of joint venture's turnover 9.8 4.3 14.3 257.6 255.2 511.1 Turnover by class of business is analysed as follows: Household products 199.3 203.0 406.6 Personal care products 33.1 41.1 71.7 Pharmaceuticals 15.4 6.8 18.5 247.8 250.9 496.8 Share of joint venture's turnover 9.8 4.3 14.3 257.6 255.2 511.1 1) Segmental information continued Unaudited Unaudited Audited 6 months 6 months Year ended to to 31 Dec 31 Dec 30 June 2000 1999 2000 £m £m £m Operating profit by geographical origin is analysed as follows: UK 7.3 8.7 17.7 Continental Europe 3.2 8.0 13.3 Operating profit 10.5 16.7 31.0 Share of joint venture after goodwill (1.9) (0.2) (2.8) Non operating items - (2.8) 0.5 Net interest payable (4.5) (2.5) (6.4) Profit on ordinary activities before tax 4.1 11.2 22.3 Operating profit by class of business is analysed as follows: Household products 8.2 15.1 28.5 Personal care products 0.4 1.0 1.4 Pharmaceuticals 1.9 0.6 1.1 Operating profit 10.5 16.7 31.0 Share of joint venture after goodwill (1.9) (0.2) (2.8) Non operating items - (2.8) 0.5 Net interest payable (4.5) (2.5) (6.4) Profit on ordinary activities before tax 4.1 11.2 22.3 2) Tax on profit on ordinary activities The Group tax charge is calculated at 25% of the profit before taxation excluding non taxable deductions, being the estimated effective rate of tax for the year to 30 June 2001. 3) Earnings per ordinary share Earnings per ordinary share is calculated on profit after tax in accordance with FRS 14. The calculation of earnings per ordinary share for the six months ended 31 December 2000 is based on 177,639,197 ordinary shares of 10p each which was the number of ordinary shares in issue at 30 June 2000 and at 31 December 1999. The weighted average number of shares in issue at 31 December 1999 and 30 June 2000 was 177,639,197. 4) Profit and loss account Unaudited Unaudited Audited 6 months to 6 months to Year Ended 31 Dec 2000 31 Dec 1999 30 June 2000 £m £m £m Goodwill reserve (146.4) (146.4) (146.4) Profit and loss account 60.3 52.6 57.6 (86.1) (93.8) (88.8) 5) Reconciliation of operating profit to operating cash flow Unaudited Unaudited Audited 6 months to 6 months to Year Ended 31 Dec 2000 31 Dec 1999 30 June 2000 £m £m £m Group operating profit 10.5 16.7 31.0 Depreciation 9.0 8.8 16.6 Other non cash items - - 0.7 Goodwill amortisation 1.0 0.5 1.5 Movement in stocks 0.1 (7.8) (7.7) Movement in debtors 1.7 (2.1) (8.3) Movement in creditors (6.3) 8.4 9.2 Cash flow from operating activities 16.0 24.5 43.0 6) Unaudited half year results The results for the half year ended 31 December 2000 and 31 December 1999 are unaudited and have been prepared on the basis of accounting policies set out in the Report and Accounts for the year ended 30 June 2000. The comparative figures for the year ended 30 June 2000 do not constitute statutory accounts. Those accounts have been reported on by the Company's auditors and delivered to the Registrar of Companies. The report of the auditors thereon was unqualified and did not contain a statement under Section 237 (2) or (3) of the Companies Act 1985. 7) Purchase of minority interest In the six months to 31 December 2000, McBride plc increased its holding in Wrafton Laboratories Ltd from 80% to 92.5% for a total consideration of £3.6 million, generating additional goodwill of £2.9 million. Financial calendar for the year ending 30 June 2001 Dividends Interim Announcement 30 March 2001 Final Announcement September 2001 Payment November 2001 Results Interim Announcement 30 March 2001 Preliminary statement for full year Announcement September 2001 Report and Accounts Circulated September 2001 Annual General Meeting To be held October 2001

Companies

Mcbride (MCB)
UK 100

Latest directors dealings